t-PA ingredient specific

retired
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.6
Version
20160331
PublisherTJC EH StewardDate2016-03-31T01:00:12-04:00Purpose

(Clinical Focus: Tissue plasminogen activator (t-PA) drugs as independent ingredients for use in noting the most general idea of t-PA ingredients appropriate for treatment of ischemic stroke. Initial use is for representation of a medication "not done". The desire is to have a single choice.),(Data Element Scope: Medication order or discharge NOT DONE),(Inclusion Criteria: Only single ingredient, ingredient-level representation of t-PA drugs),(Exclusion Criteria: None)

Expansion
<<>>>
CodeDisplaySystem
8410http://www.nlm.nih.gov/research/umls/rxnorm